Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Name: Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study
License: Public Domain

National Cancer Institute (NCI) · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

constitutional mismatch repair deficiency syndrome, hematopoietic and lymphoid cell neoplasm, lynch syndrome, recurrent lymphoma, recurrent malignant solid neoplasm, recurrent neuroblastoma

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 123435 · SHA-256 e5bfa50054351e7a
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.